| 000 | 01564 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516101042.0 | ||
| 264 | 0 | _c20121102 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1555-7162 | ||
| 024 | 7 |
_a10.1016/j.amjmed.2011.12.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKusuma, Andy | |
| 245 | 0 | 0 |
_aClinical impact of peripheral attacks in hereditary angioedema patients. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cSep 2012 |
||
| 300 |
_a937.e17-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngioedemas, Hereditary _xcomplications |
| 650 | 0 | 4 |
_aComplement C1 Inactivator Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aComplement C1 Inhibitor Protein |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPain _xetiology |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRelan, Anurag | |
| 700 | 1 | _aKnulst, André C | |
| 700 | 1 | _aMoldovan, Dumitru | |
| 700 | 1 | _aZuraw, Bruce | |
| 700 | 1 | _aCicardi, Marco | |
| 700 | 1 | _aLevy, Robyn J | |
| 700 | 1 | _aNuijens, Jan H | |
| 700 | 1 | _aHack, C Erik | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 125 _gno. 9 _gp. 937.e17-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2011.12.016 _zAvailable from publisher's website |
| 999 |
_c21907962 _d21907962 |
||